CLINICAL_TRIALS
trial_result
· 2019-10-03
Clinical Trial Update: PP100-01 (Calmangafodipir) for Overdose of Paracetamol [Phase 1]
Summary
Phase 1 clinical trial update for Calmangafodipir (PP100-01) in paracetamol overdose completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Egetis Therapeutics | Conditions: Paracetamol Overdose | Phase 1 | Status: COMPLETED | Results posted: 2019-10-03